Literature DB >> 16936168

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis.

Zachary T Bloomgarden1, Regina Dodis, Catherine M Viscoli, Eric S Holmboe, Silvio E Inzucchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16936168     DOI： 10.2337/dc06-1120

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  57 in total

1.  Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.

Authors:  Mark Ensor; Amy B Banfield; Rebecca R Smith; Jarrod Williams; Robert A Lodder
Journal:  J Endocrinol Diabetes Obes       Date:  2014-12-31

2.  Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial.

Authors:  Andreea Zurbau; Lea Smircic Duvnjak; Sasa Magas; Elena Jovanovski; Jelena Miocic; Alexandra L Jenkins; David J A Jenkins; Robert G Josse; Lawrence A Leiter; John L Sievenpiper; Vladimir Vuksan
Journal:  Eur J Nutr       Date:  2021-01-24       Impact factor: 5.614

3.  Dynamic population pharmacokinetic-pharmacodynamic modelling and simulation supports similar efficacy in glycosylated haemoglobin response with once or twice-daily dosing of canagliflozin.

Authors:  Willem de Winter; Adrian Dunne; Xavier Woot de Trixhe; Damayanthi Devineni; Chyi-Hung Hsu; Jose Pinheiro; David Polidori
Journal:  Br J Clin Pharmacol       Date:  2017-01-31       Impact factor: 4.335

Review 4.  Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions.

Authors:  Kayo Fujita; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

5.  Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.

Authors:  Neda Laiteerapong; Jennifer M Cooper; M Reza Skandari; Philip M Clarke; Aaron N Winn; Rochelle N Naylor; Elbert S Huang
Journal:  Ann Intern Med       Date:  2017-12-12       Impact factor: 25.391

Review 6.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Authors:  Kasia J Lipska; Harlan Krumholz; Tacara Soones; Sei J Lee
Journal:  JAMA       Date:  2016-03-08       Impact factor: 56.272

Review 7.  A review of the efficacy and safety of oral antidiabetic drugs.

Authors:  Stephanie Aleskow Stein; Elizabeth Mary Lamos; Stephen N Davis
Journal:  Expert Opin Drug Saf       Date:  2012-12-14       Impact factor: 4.250

Review 8.  Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence.

Authors:  Vivian A Fonseca; Yehuda Handelsman; Bart Staels
Journal:  Diabetes Obes Metab       Date:  2010-05       Impact factor: 6.577

9.  Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.

Authors:  Jeffrey W Chisholm; Allison B Goldfine; Arvinder K Dhalla; Eugene Braunwald; David A Morrow; Ewa Karwatowska-Prokopczuk; Luiz Belardinelli
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

10.  Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial.

Authors:  Priscilla A Hollander; Aslam Amod; León E Litwak; Umesh Chaudhari
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 17.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.